Procter & Gamble Health Limited (NSE:PGHL) — Market Cap & Net Worth

$1.13 Billion USD · Rs104.75 Billion INR · Rank #8529

Market Cap & Net Worth: Procter & Gamble Health Limited (PGHL)

Procter & Gamble Health Limited (NSE:PGHL) has a market capitalization of $1.13 Billion (Rs104.75 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #8529 globally and #418 in its home market, demonstrating a 1.21% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Procter & Gamble Health Limited's stock price Rs6310.50 by its total outstanding shares 16599382 (16.60 Million). Review total liabilities of Procter & Gamble Health Limited to assess the company's total debt and financial obligations.

Procter & Gamble Health Limited Market Cap History: 2015 to 2026

Procter & Gamble Health Limited's market capitalization history from 2015 to 2026. Data shows growth from $111.38 Million to $1.13 Billion (23.94% CAGR).

Index Memberships

Procter & Gamble Health Limited is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.15 Trillion	0.10%	#237 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.24 Trillion	0.03%	#354 of 750

Weight: Procter & Gamble Health Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Procter & Gamble Health Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Procter & Gamble Health Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.08x

Procter & Gamble Health Limited's market cap is 0.08 times its annual revenue

Industry average: 0.53x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.37x

Procter & Gamble Health Limited's market cap is 0.37 times its annual earnings

Industry average: 0.02x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$144.92 Million	$9.93 Billion	$791.30 Million	0.01x	0.18x
2017	$191.04 Million	$6.98 Billion	$939.10 Million	0.03x	0.20x
2018	$459.47 Million	$8.49 Billion	$8.39 Billion	0.05x	0.05x
2019	$719.69 Million	$8.89 Billion	$1.66 Billion	0.08x	0.43x
2020	$1.13 Billion	$10.09 Billion	$1.77 Billion	0.11x	0.64x
2020	$1.13 Billion	$11.55 Billion	$2.05 Billion	0.10x	0.55x
2021	$900.80 Million	$11.14 Billion	$1.93 Billion	0.08x	0.47x
2022	$675.17 Million	$12.30 Billion	$2.29 Billion	0.05x	0.29x
2023	$869.99 Million	$11.51 Billion	$2.01 Billion	0.08x	0.43x
2024	$940.31 Million	$12.18 Billion	$2.51 Billion	0.08x	0.37x

Competitor Companies of PGHL by Market Capitalization

Companies near Procter & Gamble Health Limited in the global market cap rankings as of June 19, 2026.

Key companies related to Procter & Gamble Health Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.78 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #601 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#515	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#555	GALDERMA GROUP AG	NYSE:GALDY	$48.78 Billion	$42.94
#601	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$45.20 Billion	CN¥48.42
#627	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€13.30

Procter & Gamble Health Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Procter & Gamble Health Limited's market cap moved from $111.38 Million to $ 1.13 Billion, with a yearly change of 23.94%.

Year	Market Cap	Change (%)
2026	Rs1.13 Billion	+10.65%
2025	Rs1.02 Billion	+8.88%
2024	Rs940.31 Million	+8.08%
2023	Rs869.99 Million	+28.86%
2022	Rs675.17 Million	-25.05%
2021	Rs900.80 Million	-20.39%
2020	Rs1.13 Billion	+57.23%
2019	Rs719.69 Million	+56.63%
2018	Rs459.47 Million	+140.52%
2017	Rs191.04 Million	+31.82%
2016	Rs144.92 Million	+30.11%
2015	Rs111.38 Million	--

End of Day Market Cap According to Different Sources

On Jun 19th, 2026 the market cap of Procter & Gamble Health Limited was reported to be:

Source	Market Cap
Yahoo Finance	$1.13 Billion USD
MoneyControl	$1.13 Billion USD
MarketWatch	$1.13 Billion USD
marketcap.company	$1.13 Billion USD
Reuters	$1.13 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic

Market Cap

$1.13 Billion

Rs104.75 Billion INR

Market Cap Rank

#8529 Global

#418 in India

Share Price

Rs6310.50

Change (1 day)

+0.98%

52-Week Range

Rs4778.60 - Rs6581.50

All Time High

Rs6870.36